Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (62)
  • 2024 (54)
  • 2023 (99)
  • 2022 (139)
  • 2021 (112)
  • 2020 (26)
  • 2019 (2)
  • 2018 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Major Law Enforcement Operation (267)
  • Diversion Division (242)

Drug Name

  • Fentanyl (145)
  • Cocaine (112)
  • Methamphetamine (87)
  • Heroin (76)
  • Opioids (52)
  • Oxycodone (39)
  • Synthetic Opioids (25)
  • Marijuana (Cannabis) (22)
  • Hydromorphone (13)
  • Benzodiazepines (7)
  • Morphine (7)
  • Amphetamines (3)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • K2/Spice (1)
  • Ketamine (1)
  • LSD (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • Washington, DC (149)
  • New York (40)
  • New England (37)
  • Seattle (29)
  • El Paso (27)
  • New Jersey (23)
  • St. Louis (23)
  • Chicago (22)
  • Houston (21)
  • Sede (18)
  • San Francisco (16)
  • Atlanta (15)
  • Miami (15)
  • New Orleans (11)
  • Dallas (10)
  • San Diego (10)
  • Rocky Mountain (9)
  • Los Angeles (6)
  • Phoenix (6)
  • Omaha (4)
  • Louisville (3)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Complaint Filed Against Houston Pharmacy and its Owners for Violations of the Controlled Substances Act

Abril 28, 2025
HOUSTON – A civil complaint has been filed seeking monetary penalties against a local pharmacy and its owners following an investigation revealing numerous fraudulent controlled substance prescriptions, announced Acting Special Agent in Charge William Kimbell of the Houston Division and U.S. Attorney Nicholas J. Ganjei. The complaint seeks civil monetary...
Abril 28, 2025
PRESS RELEASE

Private Shipping Company to Pay $400,000 to Settle Allegations of Transshipping Fentanyl Precursor Chemicals

Marzo 26, 2025
SAN ANTONIO – IMC Pro International Inc. has agreed to pay $400,000 to the United States to resolve allegations it violated the Controlled Substances Act through transshipping fentanyl precursor chemicals. The United States alleged IMC Pro International Inc., a North Carolina-based shipping and logistics company, entered business agreements with several...
Marzo 26, 2025
PRESS RELEASE

India-Based Chemical Company and Top Employees Indicted for Unlawful Import of Fentanyl Precursor Chemicals

Marzo 21, 2025
An India-based chemical manufacturing company and three high-level employees were charged in federal court in Washington, D.C., today related to illegally importing precursor chemicals used to make illicit fentanyl. According to the indictment, Vasudha Pharma Chem Limited (VPC), VPC Chief Global Business Officer Tanweer Ahmed Mohamed Hussain Parkar, 63, of...
Marzo 21, 2025
PRESS RELEASE

Three Wanted Defendants from Mexico Secured in Arizona

Marzo 05, 2025
PHOENIX, Ariz. – Jose Bibiano Cabrera-Cabrera, 37; Jesus Humberto Limon-Lopez, 43; and Jose Guadalupe Tapia-Quintero, 53; all of Mexico, appeared last week for their initial appearances after they were secured from Mexico on February 27, 2025. The defendants taken into U.S. custody include leaders and managers of drug cartels recently...
Marzo 05, 2025
PRESS RELEASE

Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

Febrero 27, 2025
CHARLOTTE, N.C. – Prescriptions Plus, a pharmacy in Gastonia, N.C., has agreed to pay $204,000 to resolve allegations that it violated the recordkeeping requirements of the Controlled Substances Act, announced Acting U.S. Attorney Lawrence J. Cameron. The Controlled Substances Act was enacted to combat illegal distribution and abuse of controlled...
Febrero 27, 2025
PRESS RELEASE

DEA Phoenix, Phoenix Police Department, and the Arizona Attorney General's Office Disrupt Major Transnational Criminal Organization Operating in the United States and Mexico

Febrero 20, 2025
PHOENIX, Ariz. - A multi-agency enforcement effort led by the U.S Drug Enforcement Administration, Phoenix Police Department, Arizona Attorney General's Office, and Arizona HIDTA, dubbed Operation Double Down, has wrapped up and proven successful in combating the drug trafficking epidemic of fentanyl and other illegal substances which have resulted in...
Febrero 20, 2025
PRESS RELEASE

Florence Doctor Sentenced for Distributing Oxycodone in “Sex for Scripts” Scheme

Febrero 12, 2025
FLORENCE, S.C.— David Carlos Rodriguez, Jr., 50, of Florence, was sentenced to nearly five years in federal prison after pleading guilty to distributing Oxycodone outside the scope of medical practice and without a legitimate medical purpose. Evidence presented to the court showed that Rodriguez provided 15 prescriptions for Oxycodone over...
Febrero 12, 2025
PRESS RELEASE

CBP Officer Arrested in El Paso, Charged with Alien Smuggling and Drug Trafficking

Febrero 10, 2025
EL PASO, Texas – A Customs and Border Protection officer was arrested in El Paso on criminal charges related to his alleged involvement in a conspiracy to smuggle undocumented noncitizens for financial gain and alleged drug trafficking activity. According to court documents, between on or about Dec. 21, 2023 and...
Febrero 10, 2025
PRESS RELEASE

New Haven Psychiatrist to Pay More Than $450K to Settle False Claims Act and Controlled Substances Act Allegations

Febrero 08, 2025
NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Roberto Coviello, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of the Inspector General, Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England...
Febrero 08, 2025
PRESS RELEASE

U.S. Attorney's Office, FBI, DEA, and EPA Announce Indictment in Massive Navajo Nation Marijuana Cultivation Scheme

Enero 30, 2025
ALBUQUERQUE – A federal grand jury has indicted three individuals for their alleged roles in a large-scale marijuana cultivation and distribution operation on Navajo Nation lands. The indictment, unsealed today, charges Dineh Benally, 48, his father, Donald Benally, 74, and Irving Rea Yui Lin, 73, a California resident, with multiple...
Enero 30, 2025
Showing 51 - 60 of 495 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Current page 6
  • Página 7
  • Página 8
  • Página 9
  • Página 10
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster